Sp379
PANEL DISCUSSION
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
A variety of new developments in the realms of screening and surveillance of Barrett's esophagus have occurred in recent years. This session will focus on the current evidence base for risk assessment algorithms to enhance screening uptake, new screening tools and obstacles to implementation. In addition, the area of surveillance remains problematic. this session will look at alternatives to the Seattle protocol in terms of risk assessment and enhanced surveillance. Finally the role of artificial intelligence now and in the future will be addressed.
A variety of new developments in the realms of screening and surveillance of Barrett's esophagus have occurred in recent years. This session will focus on the current evidence base for risk assessment algorithms to enhance screening uptake, new screening tools and obstacles to implementation. In addition, the area of surveillance remains problematic. this session will look at alternatives to the Seattle protocol in terms of risk assessment and enhanced surveillance. Finally the role of artificial intelligence now and in the future will be addressed.
Presenters
Tracks
Related Products
VIDEO-BASED COMPUTER AIDED DETECTION SYSTEM DETECTS BARRETT’S NEOPLASIA WITH HIGH ACCURACY DURING LIVE ENDOSCOPIC PROCEDURES: A MULTI-CENTER PILOT AND FEASIBILITY STUDY
BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT'S ESOPHAGUS RELATED NEOPLASIA: PRELIMINARY RESULTS FROM A PROSPECTIVE EUROPEAN MULTICENTER STUDY
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…
FEASIBILITY AND SAFETY OF TAILORED LYMPHADENECTOMY USING SENTINEL NODE NAVIGATED SURGERY WITH A HYBRID TRACER OF TECHNETIUM-99M AND INDOCYANINE GREEN IN HIGH-RISK T1 ESOPHAGEAL ADENOCARCINOMA PATIENTS
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
A TISSUE SYSTEMS PATHOLOGY TEST OUTPERFORMS STANDARD CLINICOPATHOLOGIC VARIABLES IN PREDICTING PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS.
Introduction: Shifts towards high-fat, low-fiber diets, may contribute to the rising incidence of esophageal adenocarcinoma (EAC). In mice high-fat diet promotes EAC, possibly through effects on the gut microbiome and the systemic bile acid pool…
